Market Research Insights

  San Francisco, 1 March 2024:  The Report  Mycoplasma Testing Market  Size, Share & Trends Analysis By Product (Instruments, Kits & Reagents), By Technology (PCR, ELISA, Direct Assay, Microbial Culture), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 The global mycoplasma testing market size is expected to reach USD 2.26 billion by 2030, registering a CAGR of 13.58% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the expansion of market includes growing demand for mycoplasma testing in biomanufacturing, emerging economies, and growing pharmaceutical outsourcing. Additionally, the market's overall growth is driven by rising cell-line contamination and innovation & research in biological sciences. Growing number of government initiatives to support pharmaceutical and biotechnology companies is also driving the market growth. The U.S. FDA proposed to remove ...

San Francisco, 1 August 2019:   The Report   Mycoplasma Testing Market   Analysis By Product, By Technology (PCR, ELISA, Direct Assay, Microbial Culture Techniques), By Application (Cell Line, Virus, & End of Production Cells Testing), By End-use, And Segment Forecasts, 2018 – 2025 The global mycoplasma testing market is expected to reach a value of USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. With growing R&D investments in the field of life sciences, the demand for mycoplasma testing products are anticipated to rise in the near future. Huge opportunities in the life sciences segment are spurring the market growth. Hence, a large amount of investment is being made in the biotechnology and pharmaceutical industries with rising level of healthcare spending across the globe. This is expected to trigger high growth of mycoplasma testing market. Investment in R&D activities by pharmaceutical and biotechnology compa...